
Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital …

Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …

A three year report by the Care Quality Commission (CQC) has found that though compassionate care is being offered broadly …

GSK’s Emma Walmsley looks set to begin her rejig of the business, as she aims to offload part of its …

An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without …

A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …

The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …

Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …

German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …

It is an odd time for Valeant, where selling a part of its business for half of what it paid, …

We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …

Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …